On the recordFebruary 23, 2021
There was not a shortage of remdesivir. There was not a problem with people who could not afford it.
Source
congress.govEditor's note · Context
Toomey disputes claims of drug shortages and affordability issues.
Share
More from Pat Toomey
Dec 13, 2022
I think there is a case to be made that there should be a regulatory regime on disclosure requirements for an issuer.
Jul 13, 2022
If an American venture capital firm, for instance, is investing in a Chinese artificial intelligence company that has ties to the Chinese military, a technology transfer that is associated with that deal that included some kind of…
Aug 1, 2022
As I've said before, Government, and especially this Administration, have often been the problem, not the solution, when it comes to housing.
Other voices in this conversation
